ibm stock hits all-time high at 283.15 usd

Published 16/06/2025, 14:48
© Reuters.

IBM (NYSE:IBM) stock has reached an all-time high, surging to $283.15 USD, with a market capitalization now exceeding $256 billion. According to InvestingPro analysis, the stock’s technical indicators suggest overbought conditions, and current valuations appear stretched with a P/E ratio of 46.6x. This milestone marks a notable increase for the tech giant, reflecting a 1-year total return of 68.79%. The significant rise in IBM’s stock price can be attributed to a variety of factors, including the company’s strategic advancements in cloud computing and artificial intelligence, which have driven investor confidence. With annual revenue of $62.8 billion, the achievement of this all-time high price level underscores the company’s robust performance and growing market presence over the past year. For detailed valuation metrics and 12 additional exclusive insights, visit InvestingPro, where you can access comprehensive research reports and expert analysis.

In other recent news, IBM has announced its ambitious plan to develop a practical quantum computer by 2029, with a larger system, named "Starling," expected by 2033. This quantum computer will be constructed in Poughkeepsie, New York, and aims to utilize about 200 logical qubits to potentially surpass the capabilities of classical computers. In a separate development, IBM has strengthened its partnership with Finanz Informatik to enhance IT services for the German Sparkassen-Finanzgruppe. This collaboration focuses on integrating IBM’s AI, automation, and hybrid cloud computing technologies to boost digital transformation and service delivery.

Furthermore, Stifel has maintained a Buy rating on IBM stock, setting a price target of $290. The firm highlights IBM’s AI initiatives and hybrid-cloud capabilities as key factors for potential earnings growth. Conversely, UBS has reiterated a Sell rating with a $170 price target, despite IBM’s focus on AI integration and advancements showcased at the Think 2025 event. Morgan Stanley (NYSE:MS) also maintained an Equalweight rating, with a $233 price target, emphasizing IBM’s strategic position in the burgeoning generative AI sector and its ability to simplify complex enterprise systems. These recent developments underscore IBM’s ongoing efforts in technological innovation and strategic partnerships.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.